Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 USD | -3.91% | +6.12% | -9.09% |
May. 13 | Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Terns Pharmaceuticals, Inc. Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.53M | Capitalization | 382M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -122M | EV / Sales 2024 * | - |
Net cash position 2024 * | 220M | Net cash position 2025 * | 199M | EV / Sales 2025 * | 72 x |
P/E ratio 2024 * |
-4.31
x | P/E ratio 2025 * |
-4.26
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.22% |
1 day | -3.91% | ||
1 week | +6.12% | ||
Current month | +16.83% | ||
1 month | +28.54% | ||
3 months | -24.94% | ||
6 months | +59.03% | ||
Current year | -9.09% |
Managers | Title | Age | Since |
---|---|---|---|
Amy Burroughs
CEO | Chief Executive Officer | 54 | Feb. 06 |
Erin Quirk
PSD | President | 53 | 18-12-31 |
Mark Vignola
DFI | Director of Finance/CFO | 47 | 20-08-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Fellows
CHM | Chairman | 67 | 20-11-30 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 20-11-30 |
Carl Gordon
BRD | Director/Board Member | 59 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.9 | -3.91% | 382,495 |
24-05-16 | 6.14 | +2.50% | 774,432 |
24-05-15 | 5.99 | 0.00% | 911,061 |
24-05-14 | 5.99 | +1.70% | 862,130 |
24-05-13 | 5.89 | +5.94% | 953,597 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.09% | 382M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- TERN Stock